Caseras, Xavier http://orcid.org/0000-0002-8490-6891
Simmonds, Emily http://orcid.org/0000-0001-5691-597X
Pardiñas, Antonio F. http://orcid.org/0000-0001-6845-7590
Anney, Richard http://orcid.org/0000-0002-6083-407X
Legge, Sophie E. http://orcid.org/0000-0001-6617-0289
Walters, James T. R.
Harrison, Neil A. http://orcid.org/0000-0002-9584-3769
O’Donovan, Michael C. http://orcid.org/0000-0001-7073-2379
Escott-Price, Valentina http://orcid.org/0000-0003-1784-5483
Funding for this research was provided by:
RCUK | Medical Research Council (MR/L010305/1, MR/P005748/1, MR/T04604X/1, MR/L023784/2)
Article History
Received: 23 February 2024
Revised: 15 March 2024
Accepted: 12 April 2024
First Online: 22 April 2024
Competing interests
: Dr. NA Harrison has received research funding from Janssen, GSK, Pfizer and Lundbeck as part of the NIMA Consortium, and has sat on advisory boards for Janssen and GSK in the last ten years; all of it unrelated with this work. Drs JTR Walters and MC O’Donovan have received grant funding from Takeda Pharmaceutical and Akrivia Health. Neither played a role in this work. All other authors report no biomedical financial interest or potential conflicts of interest.